Baclofen NDC 71930-006

NDC codes

FDA NDC Directory

Product NDC (as listed)71930-006Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71930-0006Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71930-006-12	71930000612	100 TABLET in 1 BOTTLE (71930-006-12)Marketed from May 27, 2021
71930-006-13	71930000613	1000 TABLET in 1 BOTTLE (71930-006-13)Marketed from May 27, 2021
71930-006-52	71930000652	500 TABLET in 1 BOTTLE (71930-006-52)Marketed from May 27, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Baclofen
Generic name (nonproprietary): baclofen
Active ingredients: Baclofen — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Eywa Pharma Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211555
Marketing start: May 27, 2021
Listing expires: Dec 31, 2027
Other FDA classes: GABA A Agonists (Mechanism)GABA B Agonists (Mechanism)
Identifiers: Product ID 71930-006_ff342eff-68ae-4190-96bb-f887fff1dd56SPL ID ff342eff-68ae-4190-96bb-f887fff1dd56SPL set ID 7ec59f6b-7c4f-432d-ba27-442861806b6cRxCUI 197391, 197392, 430902UNII H789N3FKE8UPC 0371930066139, 0371930066528, 0371930007521, 0371930006128, 0371930006524, 0371930066122, 0371930007125, 0371930006135, 0371930007132
Pharmacologic class: gamma-Aminobutyric Acid-ergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471930000612 followed by a unit qualifier and the quantity

Package 71930-0006-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 16, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Baclofen Tablets, USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen Tablets, USP may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen Tablets, USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson’s disease has not been established and, the…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211555

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211555
Product	Strength	Form · route	Labeler	Product NDC
Baclofen	Baclofen 10 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2289
Baclofen	Baclofen 20 mg/1	TabletOral	Bryant Ranch Prepack	71335-1664
Baclofen	Baclofen 20 mg/1	TabletOral	Eywa Pharma Inc	71930-007
Baclofen	Baclofen 5 mg/1	TabletOral	Eywa Pharma Inc	71930-066